Health

  • October 26, 2026

    Soul BnB Says Airbnb Didn't Properly Serve TM Case

    A wellness retreat company called Soul BnB asked a California federal judge on Monday to lift a default judgment in a trademark infringement lawsuit filed by Airbnb, claiming the suit was not properly served.

  • October 26, 2026

    Colo. Staffing Cos. Settle Travel Nurses' OT Suit For $7M

    Two Colorado travel nurse staffing companies and thousands of travel nurses have reached a $7 million settlement to end a class and collective action accusing the companies of underpaying their workers.

  • October 26, 2026

    3 Firms Steer Obesity Drugmaker Corxel's $377M SPAC Deal

    Obesity-focused biopharmaceutical company Corxel Pharmaceuticals Inc. on Monday unveiled plans to go public by merging with special-purpose acquisition company Amanat Acquisition Corp. in a deal expected to generate roughly $377 million in gross proceeds and that was built by three law firms.

  • October 26, 2026

    Immigrant Detainees Say ICE Is Defying Clean Facility Order

    A certified class of detainees held in a U.S. Immigration and Customs Enforcement facility in the Mojave Desert asked a California federal court again to enforce its preliminary injunction requiring humane conditions and independent monitoring.

  • October 26, 2026

    In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

    A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.

  • October 26, 2026

    Whistleblower 'Gold Rush' Might Strain DOJ, Experts Warn

    A new federal program offering cash for tips that result in criminal fraud charges is poised to set off a whistleblower "gold rush" that could uncover more fraudsters, but might also invite a high number of low-quality claims that burden businesses and strain limited U.S. Department of Justice resources, experts say.

  • October 26, 2026

    Bristol-Myers, Others Appeal Revlimid MDL To 3rd Circ.

    Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies have sought permission to file an interlocutory appeal for a sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid to the Third Circuit after a New Jersey federal judge refused to toss it.

  • October 26, 2026

    6 Firms Steer $5.7B Surgery Partners Take-Private Deal

    Healthcare services organization HealthSpan Partners on Monday announced plans to acquire short-stay surgical facility owner and operator Surgery Partners in an all-cash take-private deal valued at $5.7 billion that was built by six law firms.

  • October 26, 2026

    Mich. Panel Backs $9.7M Negligence Verdict Against Hospital

    A Michigan appeals court declined to upend a hospital's share of a $9.7 million jury verdict for administrative negligence in its care for a woman who died while receiving emergency treatment for complications following an abdominoplasty, or "tummy tuck" procedure.

  • October 26, 2026

    Texas Couple Sent To Prison For Medicare Fraud Scheme

    Husband and wife operators of a medical equipment company in Harlingen, Texas, were sentenced to serve several years in prison for defrauding Medicare out of millions of dollars for wheelchair repairs that were never performed, according to federal prosecutors.

  • October 26, 2026

    Radiology Co. Strikes Deal In ESOP Fight Ahead Of Trial

    Radiology company Envision and its trustee have settled a class action claiming they brokered an inflated $163.7 million stock sale to the business' employee stock ownership plan, staving off a bench trial that was days away from kicking off, according to a Colorado federal court filing.

  • October 23, 2026

    Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed

    A Texas federal judge has denied Strive Specialties Inc.'s bid to undo her judgment dismissing the compounding pharmacy's lawsuit that accuses Eli Lilly and Novo Nordisk of blocking competition for GLP-1 medications, saying Strive's claim that the court committed a manifest legal error was based on the company's own misunderstanding.

  • October 23, 2026

    5th Circ. Revives Facebook Users' Eyemart Wiretap Suit

    The Fifth Circuit on Friday revived a group of Facebook users' proposed class action accusing Eyemart Express LLC of disclosing their HIPAA-protected information to Meta without their consent, saying in a published opinion that Eyemart and a district court had read the statutory definition of individually identifiable health information too narrowly.

  • October 23, 2026

    Consumers Fight Bids To End Delta-8 Mislabeling Suit

    Vape maker Savage Enterprises, two distributors and a California testing lab must not be allowed to shake a lawsuit accusing them of trying to pass off vape pens with illegal levels of THC as legal hemp products, consumers told an Arkansas federal court, saying their dismissal bids are moot because there is a new complaint.

  • October 23, 2026

    J&J Wins Ohio Talc Mesothelioma Trial

    An Ohio state jury on Friday found in Johnson & Johnson's favor in a wrongful death suit brought by the family of a woman who alleged that her mesothelioma was caused by her longtime use of talc cosmetic products containing asbestos.

  • October 23, 2026

    Del. Forum Selection Clause Sinks IQVIA's NC Poaching Suit

    IQVIA Holdings Inc. should have brought its poaching suit against four former employees accused of defecting to a competitor in Delaware court under a forum selection clause in their employment contracts, a North Carolina Business Court judge ruled Thursday in dismissing the case.

  • October 23, 2026

    Baxter Says Novum Pump Issues Don't Show Securities Fraud

    A group of Baxter International shareholders should not be allowed to pursue securities fraud claims over a new fluid pump product later deemed defective simply because the product and its revenues performed worse than publicly expected, the company and its executives have told an Illinois federal judge.

  • October 23, 2026

    EEOC Suit Over Yale's Age-Based Doc Testing Headed To Trial

    A Connecticut federal judge on Friday shot down competing bids to end a U.S. Equal Employment Opportunity Commission lawsuit accusing Yale New Haven Hospital of unlawfully subjecting doctors over 70 to cognitive tests, ruling a trial is needed to determine whether patient safety concerns warranted the exams.

  • October 23, 2026

    1st Circ. Says Sinovac Investor's Fraud Suit Came Too Late

    The First Circuit found that investment management firm MW Gestion was a few months too late to sue an investor and his firm on a claim they hid their growing stake in China-based biopharmaceutical company Sinovac Biotech Ltd., upholding a lower court's ruling that ended MW Gestion's proposed class action on behalf of Sinovac shareholders.

  • October 23, 2026

    NC Asks 4th Circ. To Undo Atty Fees In Prison Trans Care Row

    North Carolina urged the Fourth Circuit on Friday to reverse over half a million dollars in legal fees awarded to a formerly incarcerated transgender woman alleging she was wrongly denied gender-affirming surgery at a state prison, arguing the award defies U.S. Supreme Court precedent.

  • October 23, 2026

    Geico Says Fla. Cos. Owe $4M For Fraudulent Billing Scheme

    A group of Geico insurers told a Florida federal court Friday that they are entitled to recover more than $4 million from healthcare companies that they say submitted thousands of fraudulent no-fault insurance claims for medically unnecessary services purportedly provided to insured car crash victims.

  • October 23, 2026

    Fenwick, Cooley Steer Lycia Therapeutics' Upsized $318M IPO

    Early-stage biotechnology firm Lycia Therapeutics began trading Friday after raising $318 million in its upsized initial public offering steered by Fenwick & West LLP and Cooley LLP.

  • October 23, 2026

    Telemed Co. Owner Gets 20 Years For $46M Medicare Scheme

    The owner of a telemedicine company was sentenced to 20 years in prison after he pled guilty to organizing and leading a $46.2 million fraud that targeted Medicare patients to get them to accept unnecessary orthotic braces and genetic tests.

  • October 23, 2026

    More Info Needed To Back Up Conduent $80M Breach Deal

    A New Jersey federal judge said a bid for preliminary approval of an $80 million settlement between data breach victims and Conduent Business Services LLC lacks the case-specific materials needed to evaluate the deal's fairness.

  • October 23, 2026

    Taxation With Representation: Milbank, De Brauw, Wachtell

    In this week's Taxation With Representation, EQT Private Equity announces a takeover offer for life sciences testing company Qiagen NV, Salesforce acquires customer engagement platform Braze and London Stock Exchange Group buys U.S. credit intelligence provider Octus.

Expert Analysis

  • Prepping Health Businesses For Sale In A Data-Driven Market

    Author Photo

    In a thinner market for healthcare transactions, with both regulators and buyers using artificial intelligence to inspect data in great detail, the margin for error in sellers' financials and legal diligence has narrowed, requiring more proactive compliance efforts, says Cody Dumas at FBFK Law.

  • Series

    Ballet Makes Me A Better Lawyer

    Author Photo

    A lifetime of learning and performing ballet taught me that success — whether in dance or practicing law — comes only through hours of thorough preparation, boundless energy and relentless effort, says Sharon Katz-Pearlman at Greenberg Traurig.

  • Rejection Of NLRB Successor Bar Renews An Employer Tool

    Author Photo

    Although the D.C. Circuit's recent ruling in Hospital Menonita v. National Labor Relations Board does not allow purchasers to disregard incumbent unions, employers acquiring a unionized business have regained a tool to challenge a union's majority support, say attorneys at Bass Berry.

  • NY Ethics Opinion Warns Attys On Qui Tam Deception

    Author Photo

    A recent New York State Bar Association ethics opinion cautions that counsel representing whistleblowers may not induce, supervise or facilitate a client's deceptive prefiling investigations, creating a potential vulnerability for qui tam complaints built on questionable evidence-gathering methods, say attorneys at Sidley.

  • DOJ Fraud Declination Highlights Self-Disclosure Tradeoffs

    Author Photo

    As exemplified by the U.S. Department of Justice's declination of charges against Campus Eye Management under its new corporate enforcement policy, self-disclosure can be an attractive option for healthcare companies navigating criminal exposure, but should be weighed against potential costs, say attorneys at Morgan Lewis.

  • Insurer Spoliation Ruling Flags Continuing Duty To Preserve

    Author Photo

    An Illinois federal court’s recent decision to impose spoliation sanctions on the insurer in H.D. Smith v. Cincinnati Insurance provides practical guidance for navigating long-tail coverage litigation, underscoring the importance of evaluating preservation obligations in light of the full life cycle of a dispute, say attorneys at Morgan Lewis.

  • What DOJ Fraud Division Rule Resolves, And What It Doesn't

    Author Photo

    The U.S. Department of Justice’s recently published final rule answers many outstanding questions about the newly created National Fraud Enforcement Division, but overlapping mandates could result in parallel investigations and diverging viewpoints between multiple sets of prosecutors, say attorneys at Gibson Dunn.

  • Series

    Taekwondo Makes Me A Better Lawyer

    Author Photo

    Taekwondo has taught me to recognize when to fight for a position and when to focus on finding a solution, and that the best outcomes are often achieved by solving problems — all of which has improved my work as a bankruptcy lawyer, mediator and Subchapter V trustee, says Amy Denton Mayer at Berger Singerman.

  • Youth Center Investigation Shows Rising Governance Scrutiny

    Author Photo

    A recent New Hampshire attorney general report following its investigation into the state's Sununu Youth Services Center shows how organizations serving vulnerable populations can face scrutiny of their governance, safety practices and preparedness, even when investigators find no abuse, say attorneys at Morgan Lewis.

  • Target's ERISA Win Doesn't Ax Tobacco Surcharge Questions

    Author Photo

    Though a Minnesota federal court's recent dismissal of a putative class action challenging Target's tobacco surcharge wellness program offers employers a defense road map, courts' differing conclusions about the Employee Retirement Income Security Act versus U.S. Department of Labor requirements leave the legal landscape unsettled, say attorneys at McGuireWoods.

  • How 'Most Favored Nation' Regime Affects Biopharma Deals

    Author Photo

    As M&A activity surges in the biopharma space, companies will need to account for the Trump administration's most-favored-nation pricing proposals — durable in concept, if unsettled in detail — when drafting deals, say attorneys at Gibson Dunn.

  • Where DOJ's Fraud Priorities Memo May Actually Matter

    Author Photo

    The U.S. Department of Justice’s recently released memo outlining priorities for its newly created fraud division will shape how cases are identified, staffed and sequenced, meaning white collar defense work must begin earlier, say David Tarras at Tarras Defense and Trevor Jones at Dynamis.

  • What To Know As Legal Duty To Consider AI Takes Shape

    Author Photo

    While the U.K. Jurisdiction Taskforce’s recent statement on liability for artificial intelligence harms is nonbinding for both U.K. and U.S. lawyers, it highlights the importance of being able to distinguish between the availability of a tool and a professional obligation to use it, say Jonny Frank and Michael Costa at StoneTurn.

  • NC Dental Review Change Counters Tougher National Trend

    Author Photo

    North Carolina’s elimination of its prior review requirement for dental management agreements departs sharply from the national trend toward expanded corporate practice of medicine oversight, but stakeholders should not view this regulatory shift as a relaxation of compliance expectations, say attorneys at Holland & Knight.

  • DOJ Healthcare Declination Offers Self-Disclosure Checklist

    Author Photo

    The U.S. Department of Justice's declination of criminal charges against Campus Eye Management signals that its new self-disclosure policy provides a real path for healthcare companies to avoid criminal exposure, but that path is paved with speed, transparency and operational remediation, says Jonathan Porter at Husch Blackwell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.